Step 1 topics → Neurology and Special Senses → Cerebral Palsy

Cerebral Palsy

USMLE Step 1 trap: Incorrectly classifies cerebral palsy as a progressive rather than static encephalopathy. Cerebral palsy is a non-progressive disorder of movement and posture caused by a static injury to the developing brain.

Cerebral palsy (CP) is a group of non-progressive movement and posture disorders caused by a static injury to the developing brain — occurring before, during, or shortly after birth. USMLE Step 1 doesn't test CP in exhaustive clinical depth, but it does test whether you can classify subtypes correctly, identify the underlying pathology (especially periventricular leukomalacia in premature infants), and recognize what distinguishes CP from progressive neurodegenerative conditions. The exam typically presents a vantage point: a premature infant with motor delays, or a question stem describing spasticity patterns that you need to match to anatomy.

The trickiest part is the subtype-to-etiology mapping. Students often conflate dyskinetic CP (basal ganglia injury, kernicterus) with spastic diplegia (white matter/corticospinal tract injury from PVL). These have distinct anatomical substrates and distinct causes — mixing them up is a classic trap. The other major pitfall is treating CP as a degenerative disease. If a question implies worsening over time or neurodegeneration, that rules CP out by definition — CP's underlying lesion is static, even if functional limitations evolve.

For USMLE Step 1, anchor on three things: the 'static encephalopathy' framing, which white matter tracts are damaged in PVL and why that produces leg-predominant spasticity, and the fact that kernicterus (bilirubin toxicity to basal ganglia) is the classic cause of dyskinetic CP, not spastic diplegia.

From real student decks
14%have cards covering this topic
8%have mature cards

A gap in most decks — fewer than half of students in our cohort have cards covering this topic.

Common misconceptions

Common mistake
Wrong: Cerebral palsy is a progressive neurodegenerative disease.
Right: Cerebral palsy is a non-progressive disorder of movement and posture caused by a static injury to the developing brain.
CP results from a fixed, one-time injury to the developing brain — it is a static encephalopathy, not a neurodegenerative process. The underlying lesion does not progress, which is exactly what distinguishes CP from conditions like leukodystrophies or metabolic encephalopathies. If a vignette describes a child whose neurological status is actively deteriorating, you should think outside CP and consider a progressive disorder.
Common mistake
Wrong: Periventricular leukomalacia in premature infants most commonly causes dyskinetic cerebral palsy.
Right: Periventricular leukomalacia damages the periventricular white matter where corticospinal fibers for the legs run, most commonly causing spastic diplegia.
PVL causes ischemic necrosis of the periventricular white matter in premature infants. The key anatomical fact is that corticospinal fibers supplying the legs are somatotopically located closest to the ventricles — so PVL preferentially damages leg motor pathways while sparing arm fibers, producing spastic diplegia (legs worse than arms). Dyskinetic CP, by contrast, comes from basal ganglia injury — classically kernicterus — not from white matter ischemia.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Know the three major CP subtypes — spastic (most common, UMN pattern), dyskinetic (choreoathetoid movements, basal ganglia injury), and ataxic (cerebellar injury) — and be able to match clinical descriptions to the correct subtype.
  2. Understand the pathologic basis of spastic diplegia in premature infants: periventricular leukomalacia (PVL) damages periventricular white matter where the corticospinal fibers controlling the lower extremities run, producing leg-predominant spasticity.
  3. Identify the key etiologies: prematurity with PVL for spastic diplegia, perinatal hypoxia/ischemia for spastic quadriplegia, and kernicterus (unconjugated bilirubin toxicity to basal ganglia) for dyskinetic CP.
  4. Recognize that CP is a static, non-progressive encephalopathy — the brain injury does not worsen over time, even though the child's functional presentation may change with development.
  5. Know that management is multidisciplinary and includes spasticity treatment (e.g., baclofen, botulinum toxin) and screening for common comorbidities like epilepsy, intellectual disability, and feeding difficulties.

Can you avoid these mistakes?

A 28-week premature infant is found at age 2 to have increased tone in both lower extremities with scissoring gait but relatively normal upper extremity function. What is the most likely underlying neuropathology, and why are the legs preferentially affected?
A full-term neonate develops severe hyperbilirubinemia in the first week of life. At age 3, the child shows involuntary writhing movements of all limbs. What type of cerebral palsy is this, and what structure was injured?
A parent asks whether their child's cerebral palsy will 'get worse over time' neurologically. How do you explain CP's natural history, and what distinguishes it from progressive brain diseases?
A vignette describes a child with CP being started on baclofen and referred to physical therapy, speech therapy, and ophthalmology. Why is multi-specialty involvement necessary — what comorbidities are you screening for?

Related topics

Neural Tube Formation and Derivatives Neural Crest Derivatives Neural Tube Defects Other Developmental Malformations

See how your Anki deck covers this topic.

Upload your deck for a free audit →